Axsome Therapeutics (AXSM) EBITDA US GAAP (year values)

2020 2021 2022 2022 2023   LTM ? CAGR 5 years ?
EBITDA, bln rub ? -99.1 -123.6 -179.8 -174.2 -225.0   -300.6  
Changes by years, y/y, % +47% +25% +46% -3% +29%     +47.1%

Axsome Therapeutics. EBITDA US GAAP, bln rub

Created with Highcharts 6.0.6-1.8-1.8-2.7-2.7-6.9-6.9-27.0-27.0-27.6-27.6-32.6-32.6-67.2-67.2-99.1-99.1-123.6-123.6-179.8-179.8-174.2-174.2-225.0-225.0-300.6-300.6201320142015201620172018201920202021202220222023LTM-350-300-250-200-150-100-500smart-lab.ru

Axsome Therapeutics. EBITDA US GAAP, changes, %

Created with Highcharts 6.0.649.149.1152.2152.2291.2291.21.91.918.418.4106.0106.047.447.424.724.745.545.5-3.1-3.129.129.133.633.620142015201620172018201920202021202220222023LTM-50050100150200250300350smart-lab.ru

Axsome Therapeutics. EBITDA US GAAP, sum by quarters, bln rub

Created with Highcharts 6.0.60.90.9-0.9-0.9-7.1-7.1-6.4-6.4-9.4-9.4-24.4-24.4-27.6-27.6-32.3-32.3-59.9-59.9-53.7-53.7-96.5-96.50.20.2-7.2-7.2-6.1-6.1-8.0-8.0-18.8-18.8-21.1-21.1-33.1-33.1-40.5-40.5-60.4-60.4-60.6-60.6-2.3-2.3-6.8-6.8-6.7-6.7-8.0-8.0-13.4-13.4-17.8-17.8-30.6-30.6-37.9-37.9-38.8-38.8-57.4-57.4-78.0-78.0-5.9-5.9-7.7-7.7-7.2-7.2-10.4-10.4-32.5-32.5-27.6-27.6-38.0-38.0-5.0-5.0-65.4-65.44 quarter3 quarter2 quarter1 quarter2014201520162017201820192020202120222023202411-300-250-200-150-100-50050smart-lab.ru

Axsome Therapeutics (AXSM) EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
EBITDA, bln rub ? -60.4 -96.5 -65.4 -78.0 -60.6   -300.6
Changes by years, y/y, % +49% +80% +1 218% +36% +0%    
Changes by quarters, q/q, % +5% +60% -32% +19% -22%    

Axsome Therapeutics. EBITDA US GAAP, bln rub

Created with Highcharts 6.0.60.90.9-2.3-2.30.20.2-0.9-0.9-5.9-5.9-6.8-6.8-7.2-7.2-7.1-7.1-7.7-7.7-6.7-6.7-6.1-6.1-6.4-6.4-7.2-7.2-8.0-8.0-8.0-8.0-9.4-9.4-10.4-10.4-13.4-13.4-18.8-18.8-24.4-24.4-32.5-32.5-17.8-17.8-21.1-21.1-27.6-27.6-27.6-27.6-30.6-30.6-33.1-33.1-32.3-32.3-38.0-38.0-37.9-37.9-38.8-38.8-40.5-40.5-59.9-59.9-53.7-53.7-5.0-5.0-57.4-57.4-60.4-60.4-96.5-96.5-65.4-65.4-78.0-78.0-60.6-60.62014Q42015Q22015Q32015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-1000-125-75-50-2525smart-lab.ru

Axsome Therapeutics. EBITDA US GAAP, changes, y/y, %

Created with Highcharts 6.0.6-194.8-194.8203.2203.2-2982.9-2982.9716.1716.130.330.3-1.2-1.2-15.6-15.6-9.9-9.9-6.7-6.718.418.431.831.846.746.745.645.668.468.4134.6134.6158.8158.8212.1212.132.332.312.412.413.113.1-15.1-15.172.072.056.756.716.916.937.737.724.024.026.826.822.322.385.585.566.366.3-86.9-86.948.148.149.149.179.879.81218.41218.435.935.90.30.32015Q42016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-4k-3k-2k-1k01k2ksmart-lab.ru

Axsome Therapeutics. EBITDA US GAAP, changes, q/q, %

Created with Highcharts 6.0.6-343.9-343.9-111.1-111.1-450.3-450.3572.1572.116.016.05.55.5-0.8-0.87.37.3-12.0-12.0-9.8-9.85.85.811.211.211.611.60.40.417.817.810.310.329.129.139.939.929.929.933.033.0-45.3-45.318.818.830.830.8-0.2-0.210.910.98.38.3-2.4-2.417.617.6-0.2-0.22.32.34.44.448.048.0-10.4-10.4-90.8-90.81056.61056.65.25.259.959.9-32.2-32.219.319.3-22.4-22.42015Q22015Q32015Q42016Q12016Q22016Q32016Q42017Q12017Q22017Q32017Q42018Q12018Q22018Q32018Q42019Q12019Q22019Q32019Q42020Q12020Q22020Q32020Q42021Q12021Q22021Q32021Q42022Q12022Q22022Q22022Q32022Q42022Q42023Q12023Q22023Q32023Q42024Q12024Q22024Q3-750-500-250025050075010001250smart-lab.ru